Mexico - North America Dermatological Drugs Market Size & Outlook

Name: Mexico - North America Dermatological Drugs Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The dermatological drugs market in Mexico - North America is expected to reach a projected revenue of US$ 690.6 million by 2033. A compound annual growth rate of 10.2% is expected of Mexico - North America dermatological drugs market from 2026 to 2033.

Mexico dermatological drugs indication outlook (Revenue, USD million, 2021-2033)
- Psoriasis
- Atopic Dermatitis (Eczema)
- Fungal infections
- Acne
- Alopecia
- Rosacea
- Others
Mexico dermatological drugs type outlook (Revenue, USD million, 2021-2033)
- Prescription
- Over-the-Counter (OTC)
Mexico dermatological drugs route of administration outlook (Revenue, USD million, 2021-2033)
- Topical Administration
- Oral Administration
- Parenteral Administration
Mexico dermatological drugs drug class outlook (Revenue, USD million, 2021-2033)
- Corticosteroids
- Retinoids
- Antibiotics
- Antifungals
- Calcineurin Inhibitors
- Others
Mexico dermatological drugs distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Others

Mexico - North America Dermatological Drugs Market Size & Outlook

Sign up - it's easy, and free!